The Libertines singer, 45, was diagnosed with the chronic disease last year, and revealed on Tuesday that he's been warned by ...
A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
The Libertines singer, 45, who was diagnosed with the chronic disease last year, has performed from a chair on the last five ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
The Libertines co-frontman Pete Doherty told fans he risks needing an amputation as he gave a health update after being ...
Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...
The Libertines singer Pete Doherty has been warned by doctors that he may need to have his toes amputated after he was ...
Pete Doherty has been told by doctors that he could 'lose' his toes amid his battle with type 2 diabetes. The Libertines ...
Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...